Zu lab Publications


Author Correction: ALK phosphorylates SMAD4 on tyrosine to disable TGF-ß tumour suppressor functions (Nature Cell Biology, (2019), 21, 2, (179-189), 10.1038/s41556-018-0264-3)
Zhang, Q, Xiao, M, Gu, S, Xu, Y, Liu, T, Li, H, Yu, Y, Qin, L, Zhu, Y, Chen, F, Wang, Y, Ding, C, Wu, H, Ji, H, Chen, Z, Zu, Y, Malkoski, S, Li, Y, Liang, T, Ji, J, Qin, J, Xu, P, Zhao, B, Shen, L, Lin, X & Feng, XH 2021, , Nature Cell Biology, vol. 23, no. 3. https://doi.org/10.1038/s41556-021-00638-5

Aggressive B-cell lymphoma with MYC/TP53 dual alterations displays distinct clinicopathobiological features and response to novel targeted agents
Deng, M, Xu-Monette, ZY, Pham, LV, Wang, X, Tzankov, A, Fang, X, Zhu, F, Visco, C, Bhagat, G, Dybkaer, K, Chiu, A, Tam, W, Zu, Y, Hsi, ED, You, H, Huh, J, Ponzoni, M, Ferreri, AJM, Møller, MB, Parsons, BM, Hagemeister, F, van Krieken, JH, Piris, MA, Winter, JN, Li, Y, Xu, B, Liu, P & Young, KH 2021, , Molecular Cancer Research, vol. 19, no. 2, pp. 249-260. https://doi.org/10.1158/1541-7786.MCR-20-0466

G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
Youssef, JG, Zahiruddin, F, Youssef, G, Padmanabhan, S, Ensor, J, Pingali, SR, Zu, Y, Sahay, S & Iyer, SP 2021, , Annals of Hematology, vol. 100, no. 3, pp. 667-673. https://doi.org/10.1007/s00277-021-04395-1

Neutralizing Aptamers Block S/RBD-ACE2 Interactions and Prevent Host Cell Infection
Liu, X, Wang, YL, Wu, J, Qi, J, Zeng, Z, Wan, Q, Chen, Z, Manandhar, P, Cavener, VS, Boyle, NR, Fu, X, Salazar, E, Kuchipudi, SV, Kapur, V, Zhang, X, Umetani, M, Sen, M, Willson, RC, Chen, SH & Zu, Y 2021, , Angewandte Chemie - International Edition. https://doi.org/10.1002/anie.202100345

Recombinant expression, characterization, and quantification in human cancer cell lines of the Anaplastic Large-Cell Lymphoma-characteristic NPM-ALK fusion protein
Kourentzi, K, Crum, M, Patil, U, Prebisch, A, Chavan, D, Vu, B, Zeng, Z, Litvinov, D, Zu, Y & Willson, RC 2020, , Scientific Reports, vol. 10, no. 1, 5078. https://doi.org/10.1038/s41598-020-61936-w

XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53
Deng, M, Zhang, M, Xu-Monette, ZY, Pham, LV, Tzankov, A, Visco, C, Fang, X, Bhagat, G, Zhu, F, Dybkaer, K, Chiu, A, Tam, W, Zu, Y, Hsi, ED, Choi, WWL, Huh, J, Ponzoni, M, Ferreri, AJM, Møller, MB, Parsons, BM, van Krieken, JH, Piris, MA, Winter, JN, Hagemeister, F, Alinari, L, Li, Y, Andreeff, M, Xu, B & Young, KH 2020, , Journal of Hematology and Oncology, vol. 13, no. 1, 148. https://doi.org/10.1186/s13045-020-00982-3

High levels of immunoglobulin expression predict shorter overall survival in patients with acute myeloid leukemia
Wu, L, Xia, M, Sun, X, Han, X, Zu, Y, Jabbour, EJ, You, MJ, Lin, P, Li, S, Xu, J, Han, H, Bueso-Ramos, CE, Medeiros, LJ, Qiu, X & Yin, CC 2020, , European Journal of Haematology, vol. 105, no. 4, pp. 449-459. https://doi.org/10.1111/ejh.13466

A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL
Xu-Monette, ZY, Zhang, H, Zhu, F, Tzankov, A, Bhagat, G, Visco, C, Dybkaer, K, Chiu, A, Tam, W, Zu, Y, Hsi, ED, You, H, Huh, J, Ponzoni, M, Ferreri, AJM, Møller, MB, Parsons, BM, Van Krieken, JH, Piris, MA, Winter, JN, Hagemeister, FB, Shahbaba, B, De Dios, I, Zhang, H, Li, Y, Xu, B, Albitar, M & Young, KH 2020, , Blood Advances, vol. 4, no. 14, pp. 3391-3404. https://doi.org/10.1182/bloodadvances.2020001949

MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma
Wang, Q, Zhao, D, Xian, M, Wang, Z, Bi, E, Su, P, Qian, J, Ma, X, Yang, M, Liu, L, Zu, Y, Pingali, SR, Chen, K, Cai, Z & Yi, Q 2020, , Blood, vol. 136, no. 22, pp. 2557-2573. https://doi.org/10.1182/blood.2020005795

Peripheral T cell lymphoma, NOS with aberrant aß and ?d T cell receptor expression in a post-heart transplant patient
Liu, S, Ewton, A, Miller, TN, Zieske, AW, Thrall, MJ, Olsen, RJ, Zu, Y & Hao, S 2020, , Journal of Hematopathology, vol. 13, no. 2, pp. 109-116. https://doi.org/10.1007/s12308-020-00393-w

Aptamer cocktail to detect multiple species of mycoplasma in cell culture
Wan, Q, Liu, X, Zeng, Z, Chen, Z, Liu, Y & Zu, Y 2020, , International journal of molecular sciences, vol. 21, no. 11, 3784. https://doi.org/10.3390/ijms21113784


T-cell lymphoma secondary to checkpoint inhibitor therapy
Anand, K, Ensor, Jr. JE, Pingali, SR, Hwu, P, Duvic, M, Chiang, S, Miranda, R, Zu, Y & Iyer, S 2020, , Journal for immunotherapy of cancer, vol. 8, no. 1, e000104. https://doi.org/10.1136/jitc-2019-000104

High-Throughput Isolation of Cell Protrusions with Single-Cell Precision for Profiling Subcellular Gene Expression
Zhang, P, Han, X, Yao, J, Shao, N, Zhang, K, Zhou, Y, Zu, Y, Wang, B & Qin, L 2019, , Angewandte Chemie - International Edition, vol. 58, no. 39, pp. 13700-13705. https://doi.org/10.1002/anie.201903694

Rapid Detection of Mycoplasma-Infected Cells by an ssDNA Aptamer Probe
Liu, Y, Jiang, W, Yang, S, Hu, J, Lu, H, Han, W, Wen, J, Zeng, Z, Qi, J, Xu, L, Zhou, H, Sun, H & Zu, Y 2019, , ACS Sensors, vol. 4, no. 8, pp. 2028-2038. https://doi.org/10.1021/acssensors.9b00582

Aptamer-Engineered Natural Killer Cells for Cell-Specific Adaptive Immunotherapy
Yang, S, Wen, J, Li, H, Xu, L, Liu, Y, Zhao, N, Zeng, Z, Qi, J, Jiang, W, Han, W & Zu, Y 2019, , Small, vol. 15, no. 22, 1900903. https://doi.org/10.1002/smll.201900903

Tracking biodistribution of myeloid-derived cells in murine models of breast cancer
Li, J, Mai, J, Hinkle, L, Lin, D, Zhang, J, Liu, X, Ramirez, MR, Zu, Y, Lokesh, GL, Volk, DE & Shen, H 2019, , Genes, vol. 10, no. 4, 297. https://doi.org/10.3390/genes10040297

ALK phosphorylates SMAD4 on tyrosine to disable TGF-ß tumour suppressor functions
Zhang, Q, Xiao, M, Gu, S, Xu, Y, Liu, T, Li, H, Yu, Y, Qin, L, Zhu, Y, Chen, F, Wang, Y, Ding, C, Wu, H, Ji, H, Chen, Z, Zu, Y, Malkoski, S, Li, Y, Liang, T, Ji, J, Qin, J, Xu, P, Zhao, B, Shen, L, Lin, X & Feng, XH 2019, , Nature Cell Biology, vol. 21, no. 2, pp. 179-189. https://doi.org/10.1038/s41556-018-0264-3

Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies
Yang, S, Li, H, Xu, L, Deng, Z, Han, W, Liu, Y, Jiang, W & Zu, Y 2018, , Molecular Therapy - Nucleic Acids, vol. 13, pp. 164-175. https://doi.org/10.1016/j.omtn.2018.08.023

Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma
Wang, X, Cao, X, Sun, R, Tang, C, Tzankov, A, Zhang, J, Manyam, GC, Xiao, M, Miao, Y, Jabbar, K, Tan, X, Pang, Y, Visco, C, Xie, Y, Dybkaer, K, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Richards, KL, Hsi, ED, Choi, WWL, van Krieken, JH, Huh, J, Ponzoni, M, Ferreri, AJM, Møller, MB, Parsons, BM, Winter, JN, Piris, MA, Li, S, Miranda, RN, Medeiros, LJ, Li, Y, Xu-Monette, ZY & Young, KH 2018, , Neoplasia (United States), vol. 20, no. 6, pp. 574-593. https://doi.org/10.1016/j.neo.2018.03.002